Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Tries to Blunt Amarin’s Free-Speech Lawsuit Over Off-Label Info
FDA Tries to Blunt Amarin’s Free-Speech Lawsuit Over Off-Label Info
FDA Tries to Blunt Amarin’s Free-Speech Lawsuit Over Off-Label Info
Submitted by
admin
on June 9, 2015 - 2:01pm
Source:
WSJ Pharmalot
News Tags:
FDA
free speech
Amarin
Headline:
FDA Tries to Blunt Amarin’s Free-Speech Lawsuit Over Off-Label Info
Do Not Allow Advertisers to Use My Personal information
